Skip to Content

TV 7 1/2 1719 (Warfarin Sodium 7.5 mg)

Pill with imprint TV 7 1/2 1719 is Yellow, Capsule-shape and has been identified as Warfarin Sodium 7.5 mg. It is supplied by Teva Pharmaceuticals USA Inc.

Warfarin is used in the treatment of prevention of thromboembolism in atrial fibrillation; antiphospholipid syndrome; deep vein thrombosis prophylaxis after knee replacement surgery; deep vein thrombosis prophylaxis after hip replacement surgery; deep vein thrombosis, first event (and more), and belongs to the drug class coumarins and indandiones. For women with mechanical heart valves: There is positive evidence of human fetal risk during pregnancy. For other pregnant populations: Not for use in pregnancy. Warfarin 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TV 7 1/2 1719

Warfarin sodium 7.5 mg TV 7 1/2 1719
Warfarin sodium 7.5 mg TV 7 1/2 1719 Front
Warfarin sodium 7.5 mg TV 7 1/2 1719 Back
Warfarin sodium 7.5 mg TV 7 1/2 1719
Warfarin sodium 7.5 mg TV 7 1/2 1719

Warfarin Sodium

Imprint:
TV 7 1/2 1719
Strength:
7.5 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Coumarins and indandiones
Pregnancy Category:
D - Positive evidence of risk - for women with mechanical heart valves
X - Not for use in pregnancy - for other pregnant populations
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA Inc
National Drug Code (NDC):
00093-1719

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide